ATLAS20/20 Biolabs (AIDX) earnings date: Nov 13, 2026
20/20 Biolabs (AIDX) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 13, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on AIDX
| Last price | $0.23 (+8.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.2% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the 20/20 Biolabs stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
20/20 Biolabs reports on Nov 13, 2026. One email the day before, with ATLAS’s read on 20/20 Biolabs. You can switch it off at any time.
Alert me before AIDX reportsFree to start. Creating an account takes under a minute.
Notify me when 20/20 Biolabs reports
Track AIDX free Add 20/20 Biolabs to a free ATLAS watchlist and see its next report date in one place.
AIDX earnings at a glance
| Next report (confirmed) | Fri, Nov 13, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Aug 14, 2026 · Miss |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | -69.8% |
| Average move around a report | ±4.8% (last 4) |
| Sector | Healthcare · Medical Devices |
20/20 Biolabs earnings history: last 4 reports
20/20 Biolabs last reported on Aug 14, 2026: EPS of -$0.26 against an estimate of -$0.12 (-116.7% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 14, 2026 | -$0.12 | -$0.26 | -116.7% | Miss | +5.8% |
| May 20, 2026 | -$0.10 | -$0.28 | -180.0% | Miss | -9.7% |
| Apr 18, 2026 | $0.39 | $0.41 | +5.1% | Beat | -3.4% |
| Apr 10, 2026 | -$0.16 | -$0.14 | +12.5% | Beat | +0.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for AIDX
See the fair value, the probability range and the earnings history of 20/20 Biolabs on its ATLAS page.
20/20 Biolabs (AIDX) stock analysisPlans from €3.99 a month.
20/20 Biolabs earnings: frequently asked questions
When does 20/20 Biolabs (AIDX) report earnings?
20/20 Biolabs is scheduled to report on Friday, November 13, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does AIDX beat earnings estimates?
Of its last 4 reports with a recorded result, 20/20 Biolabs beat the EPS estimate 2 times; the average surprise was -69.8%. Past results do not predict the next one.
How much does AIDX move around earnings?
Over its last 4 reports the stock moved an average of 4.8% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
Did 20/20 Biolabs beat earnings estimates last quarter?
20/20 Biolabs last reported on Aug 14, 2026: EPS of -$0.26 against an estimate of -$0.12 (-116.7% surprise), a miss.
How much does AIDX usually move in a day?
On a normal trading day the ATLAS model puts AIDX’s one-day range at about ±5.2%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 13, 2026
Educational information, not investment advice. Disclaimer